Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels.
Saved in:
| Title: | Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels. |
|---|---|
| Authors: | Sorokin, M.1,2,3 (AUTHOR), Ignatev, K.4 (AUTHOR), Barbara, V.4 (AUTHOR), Vladimirova, U.1,3 (AUTHOR), Muraveva, A.3 (AUTHOR), Suntsova, M.1 (AUTHOR), Gaifullin, N.5 (AUTHOR), Vorotnikov, I.6 (AUTHOR), Kamashev, D.1,3 (AUTHOR), Bondarenko, A.7 (AUTHOR), Baranova, M.7,8 (AUTHOR), Poddubskaya, E.3,7 (AUTHOR), Buzdin, A.1,2,3,9 (AUTHOR) buzdin@oncobox.com |
| Source: | Biochemistry (Moscow). Jul2020, Vol. 85 Issue 7, p758-772. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
